News

Merck has received approval from the Food and Drug Administration for Welireg, its oral inhibitor for patients with certain rare types of neuroendocrine tumors. The company said Wednesday the ...
The PAM Health Rehabilitation of Tulsa held free mini screenings to show stroke survivors a new FDA-approved rehabilitation ...
FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes ...
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...
Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...
Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...
Red dye No. 3 is now banned in the US -- but it'll take time to phase it out completely. In the meantime, the FDA just ...
FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...
The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...